Lee Pharmaceuticals, Inc. — Regulation A 1-A/A
Lee Pharmaceuticals, Inc. of Mobile, AL filed a Regulation A 1-A/A with the SEC on 2022-12-29. Aggregate offering: $50.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-12-29
- Form: 1-A/A
- Accession: 0001393905-22-000502
- Tier: Tier 2
- Total aggregate offering: $50.0M
- Issuer portion: $50.0M
- Price per security: $0.0100
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Accell Audit & Compliance, PA
- Jurisdictions: 52 states/territories
Issuer
- CIK: 0000058411
- Organized in: CO
- Incorporated: 1971
- Address: 11 N Water Street, Mobile, AL, 36602
- Phone: 307-278-1360
- Employees: 1 full-time
Financial snapshot (as filed)
- Total assets: $13K
- Cash & equivalents: $13K
- Total liabilities: $555K
- Stockholder equity: $-542K
- Net income: $-555K
People (2)
| Name | Role | Location |
|---|
| John Morgan | CEO | Shelby Township, MI |
| Jeff Turner, Esq. | Signer | Newport Beach, CA |
Other Reg A filings by this issuer (5)
More